Patent Assignment
Reel/Frame 065906/0970
Assignment of Assignor's Interest
Recorded: 2023-12-19
Pages: 15
Assignors
BEARD, CLAYTON
Executed: 2023-03-30
BHARUCHA, KAMAL
Executed: 2023-04-19
BOUGNERES, PIERRE
Executed: 2023-09-12
DAVID, ERIC
Executed: 2023-03-31
ECLOV, RACHEL
Executed: 2023-04-06
ESCANDON, RAFAEL
Executed: 2023-09-10
LAFORET, GENEVIEVE
Executed: 2023-04-05
SHAYWITZ, ADAM
Executed: 2023-03-30
Assignee
ADRENAS THERAPEUTICS, INC.
421 KIPLING STREET, PALO ALTO, CALIFORNIA, 94301
Covered Property
(1)
Gene Therapies for 21-Hydroxylase Deficiency
Application:
18/551,143 →
Publication:
US 2024/0191213
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 19, 2023
From: LE FUR, SOPHIE
To: ADRENAS THERAPEUTICS, INC.
Reel/Frame 065906/0672 →
Security Interest
Jan 17, 2024
From: CALCILYTIX THERAPEUTICS INC.; ADRENAS THERAPEUTICS INC.; PHOENIX TISSUE REPAIR, INC.; NAVIRE PHARMA, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066342/0154 →
Security Interest
Jan 19, 2024
From: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; THERAS, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066355/0126 →
Release of Security Interest in Patent Collateral
Mar 5, 2025
From: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; ML BIO SOLUTIONS INC.
Reel/Frame 070551/0095 →